4baseCare Secures $6 Million in Series A Funding
Bengaluru-based Healthcare Startup Raises Capital for Expansion
Yali Capital Leads Investment Round
Bengaluru-based healthtech startup 4baseCare has successfully raised $6 million, approximately INR 50 crores, in its Series A funding round. The round was led by Yali Capital, a New York-based venture capital firm specializing in healthcare and life sciences investments.
4baseCare is a precision oncology firm that provides personalized cancer care solutions to patients through its proprietary AI-powered platform. The company's technology leverages molecular profiling and machine learning to identify optimal treatment options, monitor disease progression, and predict treatment outcomes.
The Series A funding will enable 4baseCare to expand its operations, accelerate product development, and strengthen its presence in the global precision oncology market. The company plans to use the funds to enhance its AI platform, develop new clinical applications, and establish partnerships with leading healthcare providers.
"This funding round is a significant milestone in our journey," said Sriram Bharadwaj, CEO and co-founder of 4baseCare. "It validates our mission to transform cancer care through personalized medicine and enables us to accelerate our growth trajectory.
Yali Capital's investment in 4baseCare reflects their confidence in the company's innovative technology and experienced management team. The firm's support will be instrumental in 4baseCare's efforts to make precision oncology accessible to more patients worldwide.
Komentar